Search Results - "Antonioli, C. M."

Risk factors for Sjögren's syndrome : a case-control study by PRIORI, R, MEDDA, E, VALESINI, G, STAZI, M. A, CONTI, F, CASSARA, E. A. M, SABBADINI, M. G, ANTONIOLI, C. M, GERLI, R, DANIELI, M. G, GIACOMELLI, R, PIETROGRANDE, M

“…The aim of this study was to investigate potential risk factors for Sjögren's syndrome (SS) by means of a multi-centre case-control study, focusing in…”
Get full text

Anti‐tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs by Airò, P., Antonioli, C. M., Vianelli, M., Toniati, P.

Get full text

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results by AIRO, P, DANIELI, E, PARRINELLO, G, ANTONIOLI, C. M, CAVAZZANA, I, TONIATI, P, FRANCESCHINI, F, CATTANEO, R

“…Oral cyclophosphamide (CYC) is a promising therapy for Systemic Sclerosis (SSc)-related interstitial lung disease (ILD). The use of intravenous (i.v.) pulses…”
Get full text

The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis by Airó, P, Antonioli, C M, Motta, M, Faden, D, Chirico, G, Cattaneo, R, Tincani, A

“…The case of a woman affected by an overlap syndrome systemic lupus erythematosus/polymyositis (PM), who presented with active myositis at the start of the…”
Get full text

Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders by Cimaz, R, Meregalli, E, Biggioggero, M, Airò, P, Danieli, E, Antonioli, C M, Motta, M, Chirico, G, Columbrita, D, Frassi, M, Meroni, P L, Tincani, A

“…Immunosuppressive drugs given during pregnancy to mothers suffering from a systemic autoimmune disease (AID) can cross the placenta, thus being potentially…”
Get full text

More on anticardiolipin and anti-β2 glycoprotein I in systemic sclerosis by Antonioli, C M, Danieli, E, Airò, P, Cattaneo, R, Tincani, A

Get full text

More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis by Antonioli, C M, Danieli, E, Airò, P, Cattaneo, R, Tincani, A

Get full text

More on anticardiolipin and anti-[beta]2 glycoprotein I in systemic sclerosis by Antonioli, C M, Danieli, E, Airò, P, Cattaneo, R, Tincani, A

“…According to the Sapporo criteria 10 three patients had a significant history of pregnancy loss without thromboses: one was aCL- aβ2GPI+, but two were aCL-…”
Get full text

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms by Danieli, Elisabetta, Airò, Paolo, Bettoni, Lorenzo, Cinquini, Massimo, Antonioli, Chiara M, Cavazzana, Ilaria, Franceschini, Franco, Cattaneo, Roberto

“…The aim of this study was to evaluate health-related quality of life (HR-QOL) in patients with systemic sclerosis (SSc), to compare it with that of patients…”
Get full text

Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma by Antonioli, Chiara M, Airò, Paolo

“…We report a case of dermatomyositis that was associated with a marked expansion of circulating NK cells (CD3-CD16+) with homogeneous phenotype (CD56- CD94-…”
Get full text

More on anticardiolipin and anti-[β.sub.2] glycoprotein I in systemic sclerosis by Antonioli, CM, Danieli, E, Airo, P, Cattaneo, R, Tincani, A

Get full text

Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs by Airò, P, Antonioli, C M, Vianelli, M, Toniati, P

Get full text